FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.